Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868813 · ClinicalTrials.gov registry record
An Artificial Intelligence Assisted Telehealth Intervention to Promote Self-Management in Patients With Type 2 Diabetes Mellitus (Qualitative Interview)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 20
- Enrollment target
NCT03868813: Completed study, sponsored by University of Alabama at Birmingham.
NCT03868813 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03868813 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This protocol involves a qualitative study of the needs/preferences of people with diabetes and health coaches regarding a telehealth coaching platform for glycemic control in people with diabetes.
Primary Outcome
This interview with participants help produce knowledge on the users' expectations from a health coaching system
Interventions
- BEHAVIORAL Semi-structured Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2021-07-01 |
What the finished NCT03868813 record still lists
NCT03868813 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Semi-structured Interview is the first listed.
NCT03868813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03868813 about?
NCT03868813 is a clinical study titled "An Artificial Intelligence Assisted Telehealth Intervention to Promote Self-Management in Patients With Type 2 Diabetes Mellitus (Qualitative Interview)". This protocol involves a qualitative study of the needs/preferences of people with diabetes and health coaches regarding a telehealth coaching platform for glycemic control in people with diabetes.
What is the current status of trial NCT03868813?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-07-01. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03868813?
The interventions under investigation include: Semi-structured Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT03868813?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI